DE69130869D1 - Xanthinderivate - Google Patents

Xanthinderivate

Info

Publication number
DE69130869D1
DE69130869D1 DE69130869T DE69130869T DE69130869D1 DE 69130869 D1 DE69130869 D1 DE 69130869D1 DE 69130869 T DE69130869 T DE 69130869T DE 69130869 T DE69130869 T DE 69130869T DE 69130869 D1 DE69130869 D1 DE 69130869D1
Authority
DE
Germany
Prior art keywords
represents hydrogen
different
same
formula
xanthinderivate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130869T
Other languages
English (en)
Other versions
DE69130869T2 (de
Inventor
Fumio Suzuki
Junichi Shimada
Akio Ishii
Hiromi Nonaka
Nobuo Kosaka
Shunji Ichikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of DE69130869D1 publication Critical patent/DE69130869D1/de
Application granted granted Critical
Publication of DE69130869T2 publication Critical patent/DE69130869T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
DE69130869T 1990-10-18 1991-10-17 Xanthinderivate Expired - Fee Related DE69130869T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28017190 1990-10-18
PCT/JP1991/001420 WO1992006976A1 (fr) 1990-10-18 1991-10-17 Derive de xanthine

Publications (2)

Publication Number Publication Date
DE69130869D1 true DE69130869D1 (en) 1999-03-18
DE69130869T2 DE69130869T2 (de) 1999-06-10

Family

ID=17621294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130869T Expired - Fee Related DE69130869T2 (de) 1990-10-18 1991-10-17 Xanthinderivate

Country Status (6)

Country Link
EP (1) EP0559893B1 (de)
AT (1) ATE176470T1 (de)
CA (1) CA2094270C (de)
DE (1) DE69130869T2 (de)
ES (1) ES2130138T3 (de)
WO (1) WO1992006976A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
ATE216584T1 (de) * 1992-07-08 2002-05-15 Kyowa Hakko Kogyo Kk Xanthine-derivate als antidepressiva
TW252044B (de) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
CA2112031A1 (en) * 1992-12-24 1994-06-25 Fumio Suzuki Xanthine derivatives
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
US5703085A (en) * 1994-02-23 1997-12-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
DE69834500T2 (de) 1997-09-05 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. Xanthinderivative zur behandlung von hirnischämie
CA2315736A1 (en) 1998-01-05 1999-07-15 Eisai Co., Ltd. Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus
EP1234576B1 (de) * 1999-10-29 2006-03-08 Kyowa Hakko Kogyo Co., Ltd. Arzneimittel gegen essstörungen
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
JP4376630B2 (ja) 2002-01-28 2009-12-02 協和発酵キリン株式会社 運動障害治療剤
US20060122198A1 (en) * 2003-06-27 2006-06-08 Kyowa Hakko Kogyo Co., Ltd. Antiepileptic agent
EP1709967A4 (de) 2004-01-28 2010-09-15 Kyowa Hakko Kirin Co Ltd Mittel zur behandlung von migräne
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
JP2010511628A (ja) * 2006-12-01 2010-04-15 ギリアード・パロ・アルト・インコーポレイテッド Ａ２ａアデノシン受容体アンタゴニスト
MX2009006346A (es) * 2006-12-22 2010-03-03 Sanol Arznei Schwarz Gmbh Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos.
RU2477726C1 (ru) * 2011-10-18 2013-03-20 Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") Замещенные феноксиуксусные кислоты, их эфиры и амиды, включающие 2,6-диоксо-2,3,6,7-тетрагидро-1н-пурин-8-иловый фрагмент, - антагонисты аденозинового a2a рецептора и их применение
CN110981876B (zh) * 2018-12-21 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2028235C (en) * 1989-10-20 1997-01-21 Fumio Suzuki Condensed purine derivatives

Also Published As

Publication number Publication date
ES2130138T3 (es) 1999-07-01
DE69130869T2 (de) 1999-06-10
EP0559893B1 (de) 1999-02-03
CA2094270A1 (en) 1992-04-19
ATE176470T1 (de) 1999-02-15
EP0559893A1 (de) 1993-09-15
CA2094270C (en) 1997-01-21
WO1992006976A1 (fr) 1992-04-30
EP0559893A4 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
DE69130869D1 (en) Xanthinderivate
DK0784974T3 (da) Fremstilling af xanthinderivater i fast dispersion
GB2266717B (en) Non-migrating 1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidine 1,3,5-triazine derivatives as polymer stabilizers
EP0358190A3 (de) Polysiloxane mit sterisch gehinderten Gruppen
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
ZA200204380B (en) Partial or full A1 agonists-N6 heterocyclic 5'-thio substituted adenosine derivatives.
HUT47789A (en) Compositions containing n-/dihalogeno-acetyl/-oxazolidine derivatives as antidotum substituted with heterocyclic group at the 5-position
EP1029860A4 (de) Benzofuranderivate
DE69731556D1 (de) Fettemulsion, die ein xanthinderivat enthält
EP0472974A3 (en) Acceleration compensation by matched filtering
DE59005389D1 (de) Kompensationswaage.
EP0563386A4 (en) Anticancer composition and compound
JPS6470485A (en) Triazine compound derived from 2,2,6,6- tetramethylpiperidine
ZA917666B (en) Heterocyclic compounds.
EP0579836A4 (de)
BR9201398A (pt) Emprego de oligouretanas com pesos moleculares de 5.000 ate 50.000
MX9202909A (es) 4-[alquilcarbonil(substituidas)]-4,5-dihidro- y -4,5,6,7-tetrahidro-7-[fenil(substituidas)]pirazolo-[1,5-a]pirimidinas .
WO1997020814A1 (fr) Derives du propenone
FI940607A0 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
GB9400220D0 (en) Novel 3-(substituted methyl)-4-oxa-1-azabicycle (3.2.0) heptan-7-one derivatives useful as antitumor agents
NO932258D0 (no) Heterocykliske, skadedyrdrepende forbindelser
ZA916468B (en) Substituted heterobicyclic imidazole derivatives as paf antagonists
CA2201096A1 (en) Solid dispersion and solid dispersion dosage form of xanthine derivative
ZA915075B (en) Novel bis(4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents
ES1015051Y (es) Descensor de pesos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee